Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bausch + Lomb Corporation stock logo
BLCO
Bausch + Lomb
$17.23
+0.4%
$15.76
$13.09
$18.92
$6.13B0.56381,714 shs492,548 shs
National Vision Holdings, Inc. stock logo
EYE
National Vision
$19.76
$18.70
$14.75
$30.02
$1.58B1.042.29 million shs1.64 million shs
Envista Holdings Corporation stock logo
NVST
Envista
$27.59
-0.2%
$24.86
$18.77
$30.42
$4.50B0.862.53 million shs1.83 million shs
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
€18.98
-0.1%
€17.75
€12.89
€28.00
€5.75B0.78384,750 shs337,500 shs
7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bausch + Lomb Corporation stock logo
BLCO
Bausch + Lomb
0.00%+5.76%+15.71%+4.51%+25.23%
National Vision Holdings, Inc. stock logo
EYE
National Vision
0.00%+4.77%+18.47%-16.59%-18.21%
Envista Holdings Corporation stock logo
NVST
Envista
0.00%+2.29%+23.24%+6.90%+36.70%
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
0.00%+6.74%+2.05%+38.36%-22.58%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bausch + Lomb Corporation stock logo
BLCO
Bausch + Lomb
$17.23
+0.4%
$15.76
$13.09
$18.92
$6.13B0.56381,714 shs492,548 shs
National Vision Holdings, Inc. stock logo
EYE
National Vision
$19.76
$18.70
$14.75
$30.02
$1.58B1.042.29 million shs1.64 million shs
Envista Holdings Corporation stock logo
NVST
Envista
$27.59
-0.2%
$24.86
$18.77
$30.42
$4.50B0.862.53 million shs1.83 million shs
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
€18.98
-0.1%
€17.75
€12.89
€28.00
€5.75B0.78384,750 shs337,500 shs
7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bausch + Lomb Corporation stock logo
BLCO
Bausch + Lomb
0.00%+5.76%+15.71%+4.51%+25.23%
National Vision Holdings, Inc. stock logo
EYE
National Vision
0.00%+4.77%+18.47%-16.59%-18.21%
Envista Holdings Corporation stock logo
NVST
Envista
0.00%+2.29%+23.24%+6.90%+36.70%
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
0.00%+6.74%+2.05%+38.36%-22.58%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bausch + Lomb Corporation stock logo
BLCO
Bausch + Lomb
2.21
Hold$17.923.97% Upside
National Vision Holdings, Inc. stock logo
EYE
National Vision
2.58
Moderate Buy$30.0852.24% Upside
Envista Holdings Corporation stock logo
NVST
Envista
2.40
Hold$28.673.92% Upside
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
2.83
Moderate BuyN/AN/A

Current Analyst Ratings Breakdown

Latest EYE, NVST, BLCO, and STVN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/2/2026
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
DowngradeHold (C-)Sell (D+)
6/18/2026
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
UpgradeSell (D+)Hold (C-)
6/17/2026
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
UpgradeStrong-Buy
6/16/2026
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
Initiated CoverageBuy$25.00
6/11/2026
Envista Holdings Corporation stock logo
NVST
Envista
Lower Price TargetOverweight$34.00 ➝ $32.00
6/8/2026
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
Reiterated RatingSell (D+)
6/2/2026
Bausch + Lomb Corporation stock logo
BLCO
Bausch + Lomb
Set Price TargetBuy$19.00
6/2/2026
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
Initiated CoverageOutperform$21.00
6/1/2026
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
UpgradeStrong-Buy
5/15/2026
National Vision Holdings, Inc. stock logo
EYE
National Vision
Lower Price TargetBuy$40.00 ➝ $39.00
5/14/2026
National Vision Holdings, Inc. stock logo
EYE
National Vision
UpgradeHold (C-)Hold (C)
(Data available from 7/4/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bausch + Lomb Corporation stock logo
BLCO
Bausch + Lomb
$5.10B1.21$1.68 per share10.28$18.40 per share0.94
National Vision Holdings, Inc. stock logo
EYE
National Vision
$1.99B0.80$1.79 per share11.04$10.96 per share1.80
Envista Holdings Corporation stock logo
NVST
Envista
$2.72B1.65$2.17 per share12.73$18.89 per share1.46
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
€1.34B4.28€0.88 per share21.54€5.55 per share3.42
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bausch + Lomb Corporation stock logo
BLCO
Bausch + Lomb
-$360M-$0.62N/A16.100.53-4.21%3.60%1.69%7/29/2026 (Estimated)
National Vision Holdings, Inc. stock logo
EYE
National Vision
$29.60M$0.5734.6725.011.722.31%6.41%2.81%8/5/2026 (Estimated)
Envista Holdings Corporation stock logo
NVST
Envista
$47M$0.4167.2817.801.572.41%7.11%3.91%8/5/2026 (Estimated)
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
€158.21M€0.5932.1823.731.7511.76%10.27%6.08%N/A

Latest EYE, NVST, BLCO, and STVN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/29/2026Q2 2026
Bausch + Lomb Corporation stock logo
BLCO
Bausch + Lomb
$0.16N/AN/AN/A$1.37 billionN/A
5/13/2026Q1 2026
National Vision Holdings, Inc. stock logo
EYE
National Vision
$0.43$0.45+$0.02$0.38$545.09 million$543.88 million
5/8/2026Q1 2026
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
€0.12€0.11-€0.01€0.10N/A€273.57 million
5/6/2026Q1 2026
Envista Holdings Corporation stock logo
NVST
Envista
$0.31$0.36+$0.05$0.23$680.04 million$705.50 million
4/29/2026Q1 2026
Bausch + Lomb Corporation stock logo
BLCO
Bausch + Lomb
$0.06$0.08+$0.02-$0.20$1.22 billion$1.24 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Bausch + Lomb Corporation stock logo
BLCO
Bausch + Lomb
N/AN/AN/AN/AN/A
National Vision Holdings, Inc. stock logo
EYE
National Vision
N/AN/AN/AN/AN/A
Envista Holdings Corporation stock logo
NVST
Envista
N/AN/AN/AN/AN/A
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
N/AN/AN/AN/A1 Years

Latest EYE, NVST, BLCO, and STVN Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/10/2026
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
annual€0.050.31%6/11/20266/11/20267/29/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bausch + Lomb Corporation stock logo
BLCO
Bausch + Lomb
0.78
1.53
0.99
National Vision Holdings, Inc. stock logo
EYE
National Vision
0.25
0.62
0.37
Envista Holdings Corporation stock logo
NVST
Envista
0.47
2.44
2.06
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
0.21
1.63
1.11

Institutional Ownership

CompanyInstitutional Ownership
Bausch + Lomb Corporation stock logo
BLCO
Bausch + Lomb
11.07%
National Vision Holdings, Inc. stock logo
EYE
National Vision
N/A
Envista Holdings Corporation stock logo
NVST
Envista
N/A
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
N/A

Insider Ownership

CompanyInsider Ownership
Bausch + Lomb Corporation stock logo
BLCO
Bausch + Lomb
1.45%
National Vision Holdings, Inc. stock logo
EYE
National Vision
2.40%
Envista Holdings Corporation stock logo
NVST
Envista
0.99%
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
0.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Bausch + Lomb Corporation stock logo
BLCO
Bausch + Lomb
13,000357.04 million351.87 millionOptionable
National Vision Holdings, Inc. stock logo
EYE
National Vision
13,13880.12 million78.19 millionOptionable
Envista Holdings Corporation stock logo
NVST
Envista
12,000162.73 million161.12 millionOptionable
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
6,010302.84 million300.72 millionOptionable

Recent News About These Companies

Stevanato Group (NYSE:STVN) Shares Gap Up - What's Next?
TD Cowen Initiates a Buy Rating on Stevanato Group (STVN)
STVN Share News Today

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Bausch + Lomb stock logo

Bausch + Lomb NYSE:BLCO

$17.23 +0.07 (+0.42%)
Closing price 07/2/2026 03:59 PM Eastern
Extended Trading
$17.14 -0.09 (-0.50%)
As of 07/2/2026 06:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, South Korea, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products comprising over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. Its Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation is a subsidiary of Bausch Health Companies Inc.

National Vision stock logo

National Vision NASDAQ:EYE

$19.76 0.00 (0.00%)
Closing price 07/2/2026 04:00 PM Eastern
Extended Trading
$19.76 0.00 (0.00%)
As of 07/2/2026 06:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services. National Vision Holdings, Inc. was founded in 1990 and is headquartered in Duluth, Georgia.

Envista stock logo

Envista NYSE:NVST

$27.59 -0.04 (-0.16%)
Closing price 07/2/2026 03:59 PM Eastern
Extended Trading
$27.63 +0.04 (+0.16%)
As of 07/2/2026 07:14 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

Stevanato Group stock logo

Stevanato Group NYSE:STVN

€18.98 -0.02 (-0.08%)
Closing price 07/2/2026 03:59 PM Eastern
Extended Trading
€19.01 +0.03 (+0.14%)
As of 07/2/2026 06:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.